Cargando…

Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension

Heart failure with preserved ejection fraction (HFpEF) currently has no therapies that improve mortality. Right ventricular dysfunction and pulmonary hypertension are common in HFpEF, and thought to be driven by obesity and metabolic syndrome. Thus, we hypothesized that an animal model of obesity-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Vineet, Fortune, Niki, Yu, Sheeline, Fuentes, Julio, Shi, Fubiao, Nichols, David, Gleaves, Linda, Poovey, Emily, Wang, Thomas J., Brittain, Evan L., Collins, Sheila, West, James D., Hemnes, Anna R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923530/ https://www.ncbi.nlm.nih.gov/pubmed/31903184 http://dx.doi.org/10.1177/2045894019895452

Ejemplares similares

l‐Carnitine therapy improves right heart dysfunction through Cpt1‐dependent fatty acid oxidation
por: Agrawal, Vineet, et al.
Publicado: (2022)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Adverse physiologic effects of Western diet on right ventricular structure and function: role of lipid accumulation and metabolic therapy
por: Brittain, Evan L., et al.
Publicado: (2018)

A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific
por: Talati, Megha, et al.
Publicado: (2023)

Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension
por: Trammell, Aaron W., et al.
Publicado: (2017)

Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor
por: Jia, Brigitte, et al.
Publicado: (2023)

Testosterone negatively regulates right ventricular load stress responses in mice
por: Hemnes, Anna R., et al.
Publicado: (2012)

The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension
por: Meoli, David F., et al.
Publicado: (2017)

Disproportionate cardiac hypertrophy during early postnatal development in infants born preterm
por: Aye, Christina Y L, et al.
Publicado: (2017)

Diet-dependent natriuretic peptide receptor C expression in adipose tissue is mediated by PPARγ via long-range distal enhancers
por: Shi, Fubiao, et al.
Publicado: (2021)

Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2022)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

Novel roles of cardiac natriuretic peptides in renal compensatory hypertrophy
por: Schreiber, Andrea, et al.
Publicado: (2015)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms
por: Meegan, Jamie E., et al.
Publicado: (2023)

SAT-080 Dexamethasone Administration Stimulates Acute Increases in Natriuretic Peptides in Humans: A Potential Diagnostic Test for "Natriuretic Peptide Hormone Deficiency"?
por: Bachmann, Katherine, et al.
Publicado: (2019)

Echocardiographic evaluation of diastolic function in the setting of pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2019)

Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance
por: Wu, Wei, et al.
Publicado: (2017)

Reduced free-living activity levels in pulmonary arterial hypertension patients
por: Halliday, Stephen J., et al.
Publicado: (2018)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
por: Patel, Ravi B., et al.
Publicado: (2021)

Curcumin Attenuation of Lipopolysaccharide Induced Cardiac Hypertrophy in Rodents
por: Chowdhury, Rupak, et al.
Publicado: (2013)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Echocardiographic Detection of Occult Diastolic Dysfunction in Pulmonary Hypertension After Fluid Challenge
por: Agrawal, Vineet, et al.
Publicado: (2019)

Structural Dissection of the Maltodextrin Disproportionation Cycle of the Arabidopsis Plastidial Disproportionating Enzyme 1 (DPE1)
por: O'Neill, Ellis C., et al.
Publicado: (2015)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
por: Brittain, Evan L., et al.
Publicado: (2020)

Introduction to session on undue and disproportionate influences
por: Ingle, James N, et al.
Publicado: (2010)

The megabiota are disproportionately important for biosphere functioning
por: Enquist, Brian J., et al.
Publicado: (2020)

The disproportionate burden of COVID-19 in Africa
por: Ogunbiyi, Obashina
Publicado: (2022)

Wildfires disproportionately affected jaguars in the Pantanal
por: de Barros, Alan Eduardo, et al.
Publicado: (2022)

Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension
por: Babu, Gautam, et al.
Publicado: (2023)

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2023)

Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction
por: Tate, Samuel, et al.
Publicado: (2014)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction
por: Tanaka, Komei, et al.
Publicado: (2016)

Right ventricular plasticity and functional imaging
por: Brittain, Evan L., et al.
Publicado: (2012)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Disproportionate Impact of Sexually Transmitted Diseases on Women
por: Aral, Sevgi O., et al.
Publicado: (2004)

Reforming the Medicaid Disproportionate Share Hospital Program
por: Coughlin, Teresa A., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_koee4t16c1sl9f896a6830ve1c